Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton Due to Vial Breakage


Risk Statement: The product poses a potential safety concern with vial breakage and flying glass when pressurized while preparing the product for administration. Exela has received five (5) reports of flying glass injuring skin, eye and/or other parts. There have been no reports of sterility failur (US Food Recalls) More More

Similar stories

Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall ... - FDA.gov

Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall ...  FDA.gov

Posted on 28 November 2022 | 3:00 am | Google News

Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of ... - FDA.gov

Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of ...  FDA.gov

Posted on 13 October 2022 | 2:00 am | Google News

Copyright © 2023 LastMinuteStuff.com | Contact info